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Introduction
Pathological angiogenesis, or neovascularization, is one of the vital characteristics in tumor development and hypoxia-induced ocular diseases [1] . Hypoxia is a primary etiological factor causing neovascularization [2] . One of the critical pathways regulated by hypoxia is the hypoxia inducible factor 1α (HIF-1α) pathway. Under hypoxic conditions, it has been found that HIF-1α over-expression stimulates the transcription of its downstream target genes involved in neovascularization, promoting glucose metabolism and cell proliferation. The inhibition of HIF-1α activity distinctly slows tumor growth and activates radiochemotherapic sensitivity in tumor cells [3, 4] .
Survivin is a novel member of the inhibitor of apoptosis protein (IAP) family, which regulates apoptosis and the cell cycle. Survivin expression can be induced by hypoxia [5] , correlates strongly with cell proliferation, and promotes angiogenesis [6] . Increasing evidence suggests that survivin is highly expressed in most human tumors and is closely associated with tumor progression, tumor recurrence, chemotherapy resistance and poor prognosis [7] . HIF-1α appears to be involved in regulating survivin expression in multiple tumors and hypoxia-induced cancer cell lines [8, 9] . Our previous study also found that both molecules are involved in retinal neovascularization, and HIF-1α may be a major transcription factor in regulating survivin expression in retinal neovascularization [10] .
Cyclooxygenase-2 (Cox-2), an isoform of cyclooxygenase, converts arachidonic acid into various prostaglandins (in particular prostaglandin E2, PGE 2 ) in response to hypoxia and is associated with neovascularization, tumor growth and cellular migration [11] . Recently, Bai et al. [12] revealed that PGE 2 plays an important role in the regulation of survivin expression in hepatocellular carcinoma cells. Our preliminary experiments found that both Cox-2 and survivin expression were increased in a mouse model of hypoxia-induced retinopathy [10, 13] . Accordingly, we hypothesized that Cox-2 may also play a key role in survivin upregulation. Additionally, our preliminary experiments demonstrated that rofexocib, a highly selective Cox-2 inhibitor, attenuated retinal angiogenesis by inhibiting Cox-2 expression [13] . We hypothesized that there may be some links among the pathways through which HIF-1α, survivin and Cox-2 are regulated in hypoxia-induced retinal neovascularization. As endothelial cells (ECs) are the main cell types involved in neovascularization [14] , we sought to use an in vitro model of human umbilical vein endothelial cells (HUVECs) to explore the roles of HIF1-α, Cox-2 and its product, PGE 2 , in the mechanisms underlying hypoxia-induced survivin expression. We also aimed to investigate the effect of celecoxib, a safer selective Cox-2 inhibitor than rofexocib, on hypoxia-induced survivin up-regulation in HUVECs.
Materials and Methods
Cell culture and experimental protocols HUVECs (SIBS, CAS. Code: ECV304) were maintained in RPMI-1640 medium (GIBCO, USA) supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. All cells were cultured in 25 cm 2 flasks and maintained in an incubator supplied with 95% air, 5% CO 2 and 100% humidity at 37°C. Fresh RPMI-1640 medium was changed every three days. Cells were washed twice with phosphatebuffered solution (PBS) and detached with 0.25% trypsin plus 0.05% ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, St. Louis, MO, USA) for passage. Passage 3 -5 HUVECs were used in our experiments. With 80% confluence, HUVECs were serum-starved for 16 hrs and then exposed to an environment of 3% O 2 , 5% CO 2 , 92% N 2 , at 37°C for 6, 12 and 24 hrs. In other experiments, a chemical hypoxia model was established by adding 125 µM CoCl 2 in HUVEC culture medium for 6, 12, or 24 hrs to mimic a hypoxic environment.
To investigate the effect of celecoxib on HUVEC proliferation, 15, 30, 65 or 100 μM of celecoxib was added separately in the culture medium of serum-starved HUVECs for 4 hrs, and the cells were then exposed to hypoxia. In some experiments, 5 μM PGE 2 was added to hypoxic-treated HUVECs for 24 hrs in the presence of 65 μM of celecoxib. To study the effect of HIF-1α on survivin expression, HUVECs were pre-incubated Immunocytochemistry method 1 × 10 4 HUVECs with or without hypoxic treatment were seeded on coverslips placed in wells of six-well plates. The experimental protocol followed the instruction of the strep avidin-biotin complex method (Beijing Zhongshan Golden Bridge Biotechnology, Beijing, China). Briefly, HUVECs grown on glass coverslips were fixed with 4% paraformaldehyde for 20 -30 min, washed with PBS three times and air-dried at 4°C. HUVECs were then treated with 3% hydrogen peroxide for 15 min at room temperature to block intrinsic peroxidase and washed with PBS three times. Fixed cells were incubated for 1 hr at 37°C with the following primary antibodies (rabbit polyclonal antibodies, Santa Cruz, CA): Cox-2 (1:200 in PBS), HIF-1α (1:200 in PBS) and survivin (1:100 in PBS). A negative control was incubated with PBS instead of primary antibody. Subsequently, cells were washed in PBS and incubated with biotin-conjugated goat anti-rabbit IgG (Santa Cruz, CA, USA) for 1 hr at 37°C before they were incubated with horseradish peroxidase labeled streptavidin for 20 min at 37°C and developed using the chromogen 3,3′-diaminobenzidine (DAB; Beijing Zhongshan-Golden Bridge Biotechnology). Five independent experiments were performed. The coverslips were mounted and analyzed using microscopy (Nikon, Japan). Protein expression was semi-quantitatively evaluated according to the immunohistochemical score (IHS) [15] : 0, no labeling; 1+, mild labeling (< 30% positive cells); 2+, moderate labeling (30-70% positive cells) and 3+, intense labeling (> 70% positive cells).
3-(4, 5-dimethylthazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay
An MTT assay was performed to examine the effect of celecoxib on the growth of HUVECs under normoxic or hypoxic conditions. IC 50 values of celecoxib were obtained through dose-response curves. Cells were seeded at 5 × 10 3 / well in 96-well plates continuously cultured for 24 hrs under normoxic conditions. The cells were incubated with medium plus 15, 30, 65 or 100 μM of celecoxib under hypoxic conditions for 24 hrs. The cells within these groups were supplemented with 20 μmol/dL MTT and incubated for another 4 hrs. The culture medium was then removed and 150 μl/well dimethyl sulfoxide (DMSO) was added, which enabled MTT crystals to completely dissolve. An enzyme-linked immunoassay analyzer determined the absorbance of each well at 490 nm (A490). The inhibition rates of cell growth were calculated based on a published formula [16] .
Quantitative real-time RT-PCR
Total RNA under hypoxic treatment for 0, 6, 12 or 24 hrs was extracted with Trizol reagent (Life Technologies, Carlsbad, USA) according to the manufacturer's instruction. The reverse transcription reaction was performed using the PrimeScript RT reagent Kit (TaKaRa, Dalian, China). The PCR reaction was performed using the SYBR Green Kit (Toyobo, Shang Hai, China) in a thermal cycler (Applied BiosystemsStepOne, America). β-actin was used as an internal control. The following primers were used: survivin: forward 5' AGC CCT TTC TCA AGG ACC AC3'; reverse 5'CAG CTC CTT GAA GCA GAA GAA 3'; Cox-2: forward 5'TGA GCA TCT ACG GTT TGCTC3'; reverse 5'TGC TTG TCT GGA ACA ACTGC 3': HIF-1α: forward 5'TCA TCC AAG AAG CCC TAACG3'; reverse 5'TCG CTT TCT CTG AGC ATT CTGC3'; β-actin: forward 5' ATA GCA CAG CCT GGA TAG CAA CGTAC3'; reverse 5'CAC CTT CTA CAA TGA GCT GCG TGTG3'.
The PCR reactions consisted of 6 min at 95°C, 40 cycles at 95°C for 20 seconds, 60°C for 10 seconds and 72°C for 20 seconds.
Western blot analysis
Cells cultured under hypoxic conditions for 0, 6, 12 or 24 hrs were collected and lysed in RIPA buffer (Cell Signaling Technology, containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, and 0.1% SDS) and incubated on ice for 30 min. The protein concentration was measured using the Bradford method with reagents from Bio-Rad (Hercules, CA, USA). Cell extracts (50 μg of protein) were subjected to 10% SDS-PAGE and transferred to a nitrocellulose membrane (Hybond C, Amersham, and Piscataway New Jersey, USA). Membranes were blocked with 5% (w/v) nonfat milk and probed with rabbitanti human polyclonal antibodies (Cox-2, 1:300; HIF-1α, 1:200; survivin, 1:400) (Santa Cruz, CA, USA) and a mouse anti-human β-actin monoclonal antibody (1:400) at 4°C overnight. The membranes were incubated 
Chemical hypoxia model
To assess whether hypoxia-induced HIF-1α up-regulation alone may result in elevated expression in survivin, a chemical hypoxia model was developed to stimulate HIF-1α up-regulation. A chemically induced hypoxic environment was created by exposing cells to 125 µM cobalt chloride (CoCl 2 , Sigma-Aldrich, Dorset, UK) for 6, 12 or 24 hrs. The levels of HIF-1α and survivin were determined by Western blot analysis.
PGE 2 assay
Increasing evidence indicates that PGE 2 regulates the expression of survivin in some cancer cells [17] . However the reports on survivin expression in HUVECs are rare. To investigate the levels of PGE 2 protein secreted by HUVECs exposed to normoxia, hypoxia alone or hypoxia plus 65 μM celecoxib for 24 hrs, the supernatants were collected for analysis using a PGE 2 ELISA kit (R&D Systems, Inc., Minneapolis, MN, USA) according to the manufacturer's protocol.
Effects HIF-1α inhibition on survivin expression HIF-1α is involved in the regulation of survivin expression under hypoxic conditions [18] . Genistein has been found to attenuate HIF-1α gene expression [19, 20] and was therefore applied as a HIF-1α inhibitor as described in another study [21] to explore whether hypoxia-induced HIF-1α is the only pathway that induces survivin expression. HUVECs were cultured under hypoxic conditions for 24 hrs in the presence of 50, 100 or 200 μM genistein. The cells were collected, and the levels of HIF-1α and survivin were determined by Western blot.
Effects of celecoxib on protein expression of Cox-2 and survivin
Cox-2 was reported to be involved in survivin regulation in human cancer cells [22] , but its effects in HUVECs have not been reported in detail. We used celecoxib (Sigma, USA) to inhibit Cox-2 expression. Our preliminary tests showed that increased survivin expression was most prominent 24 hrs after hypoxic treatment, so this time point was chosen in the present study. Celecoxib was added to the HUVEC medium for 4 hrs before hypoxic treatment. The minimum effective concentration (MEC) of inhibitor necessary for significant inhibition of survivin protein expression was determined by a concentration gradient test in which celecoxib was used at final concentrations of 15, 30, 65 or 100 μM. HUVECs were exposed to hypoxia for 24 hrs in the presence of the indicted concentrations of celecoxib and then collected for survivin and Cox-2 assays.
Effects of exogenous PGE 2 on hypoxia-induced survivin expression in the presence of celecoxib
Cox-2-mediated production of PGE 2 is involved in cancer cell growth [23] , and survivin is also implicated in cell growth in many cancers [24] . Interestingly, survivin and Cox-2 are often co-expressed [25] . Selective Cox-2 inhibitors have been reported to induce cell apoptosis by decreasing survivin expression [26] . Survivin protein stabilization is also modulated by PGE 2 [27] , as treatment with PGE 2 significantly increases survivin expression in human cancer cell lines [28] , but the mechanisms involved in PGE 2 -mediated survivin expression in HUVECs remain unclear. To exclude the hypothesis that exogenous PGE 2 could be a confounding factor contributing to the effects of Cox-2 on hypoxia-induced survivin expression in HUVECs, 5 μM of PGE 2 was added to HUVECs exposed to hypoxia for 24 hrs in the presence of 65 μM of celecoxib. The cells were then collected for survivin assays by Western blot.
Statistical analysis
Statistical analysis was performed using SPSS10.0 software. One-way analysis of variance (ANOVA) was used to evaluate the differences among the groups. A p-value < 0.05 was considered to be statistically significant.
Hypoxia increases mRNA and protein expression of HIF-1α, Cox-2 and survivin
In normoxia, mRNA and protein expression of HIF-1α and survivin were hardly detectable in HUVECs. The mRNA (Fig. 3A) and protein levels ( Fig. 3B & C) of Cox-2, HIF-1α and survivin were significantly elevated by hypoxia in a manner dependent on the length of time of exposure. Cox-2 expression increased at 6 hrs and peaked at 12 hrs. HIF-1α and survivin expression peaked at 12 hrs and 24 hrs, respectively, with the expression of HIF-1α maintained at 24 hrs. 6 . Effects of celecoxib and PGE 2 on Cox-2 and survivin expression in HUVECs under normoxic and hypoxic conditions. To test the concentration-dependent effect of celecoxib on the expression of hypoxia-induced survivin, different concentrations (15, 30, 65, 100 μM) of celecoxib were added to HUVEC medium 4 hrs before hypoxic treatment. To test the effect of exogenous PGE 2 on hypoxia-induced survivin expression in the presence of celecoxib, 5 μM PGE 2 was introduced to HUVEC culture media exposed to hypoxia for 24 hrs in the presence of 65 μM celecoxib. The cells were collected to assay survivin and Cox-2 levels by Western blotting. β-actin levels served as a loading control, and the relative expression levels of Cox-2 and survivin were normalized to β-actin.
Inhibition of hypoxia-induced survivin expression by genistein
We used genistein to block the pathway of HIF-1α induced gene expression. As shown in Fig. 5A & 5B, compared with vehicle treatment, HIF-1α expression was significantly reduced in the presence of 50, 100 or 200 µM genistein under hypoxic conditions for 24 hrs. The dose-dependent inhibitory effects of genistein on hypoxia-induced survivin expression were shown in the following order: 200 µM > 100 µM > 50 µM. Genistein, however, was unable to fully compensate for the increased survivin expression because it was still positive in the presence of 200 µM genistein.
Up-regulation of hypoxia-induced survivin was suppressed by celecoxib
Treatment with increasing doses of celecoxib (15-100 μM) in HUVECs under hypoxic conditions for 24 hrs significantly reduced the protein expression of Cox-2 and survivin in a dose-dependent manner. Celecoxib (15 Fig. 7 . PGE 2 protein concentrations in the medium, as analyzed by ELISA assay. HUVECs exposed to normoxia, hypoxia alone or hypoxia plus 65 μM celecoxib for 24 hrs were collected for the analysis.
μM) partially diminished hypoxia-induced Cox-2 expression, as did 30 μM celecoxib, while 65 μM celecoxib almost completely abolished elevated Cox-2 and survivin expression. PGE 2 partially reversed the inhibitory effect of celecoxib on hypoxia-induced survivin expression, while reduced Cox-2 expression by celecoxib also underwent simultaneous reversal (Fig. 6A  & 6B) .
Effects of hypoxia and celecoxib on PGE 2 activation PGE 2 production in HUVECs exposed to hypoxia for 24 hrs increased compared to the control (p < 0.05). Compared with hypoxia treatment alone, celecoxib reduced PGE 2 expression (p < 0.05) (Fig. 7) .
Discussion
HIF is the key regulator of oxygen homeostasis [29] . In our study, approximately 24 hrs after hypoxic treatment, HIF-1α protein was predominantly expressed in the nucleus and neoplasm, consistent with the theory that HIF-1α tends to be stabilized as a result of hypoxia-induced inhibition of PHD and FIH activities and then translocates to the nucleus [30] . In addition, HIF-1α regulation mainly occurs at the post-translational level and is related to changes in oxygen tension. By blocking HIF-1α degradation, CoCl 2 produces an in vitro hypoxic environment, comparable to that created by in vivo hypoxia [31] . Our study demonstrated that CoCl 2 and hypoxia-induced HIF-1α accumulation could stimulate survivin expression in ECs in a time-dependent manner; under both treatments, HIF-1α protein expression was time-dependent, whereas its mRNA expression remained stable, in line with the findings by a recent review on hypoxia [32] . Meanwhile, hypoxia is a major stimulator of Cox-2 expression resulting from HIF-1α binding to a hypoxia response element within the Cox-2 promoter interacting with HIF-1α [33] . Hypoxia-regulated Cox-2 and HIF-1α expression play critical roles in pathological neovascularization [34] . Expression of HIF-1α, Cox-2 and survivin were up-regulated by hypoxia at both the gene and protein levels in ECs in our study.
Cox-2 is associated with inflammation, angiogenesis, proliferation and tumor growth. The mechanism of its hypoxia-induced pathway, however, is still poorly understood. As a selective Cox-2 inhibitor, celecoxib has been accepted by the Food and Drug Administration (FDA) as a potent antiangiogenic and antitumor activity drug in the treatment of human cancer [35] . We found that the up-regulation of Cox-2 and survivin was induced by hypoxia, with elevated mRNA and protein expression of survivin occurring after Cox-2 induction. Additionally, hypoxia-induced survivin expression was reduced in the presence of 30 μM celecoxib, compared to that in the presence of 15 μM celecoxib, indicating hypoxia-induced survivin is a downstream gene of Cox-2 in HUVECs. These findings are consistent with other studies that suggest survivin and Cox-2 are often co-expressed in many cancers [36] .
Cox-2 and PGE 2 are up-regulated in many cancer tissues and can be suppressed by Cox-2 inhibitors [37] . The present study found that expression of PGE 2 and Cox-2 were elevated simultaneously under hypoxia. The findings that celecoxib dramatically reduced PGE 2 production and PGE 2 partially blocked the inhibitory effect of celecoxib on hypoxiainduced survivin expression suggest that PGE 2 may be a mediator of Cox-2-induced survivin up-regulation. It is well established that Cox-2/PGE 2 stimulates VEGF expression through the HIF-1α pathway and contributes to tumor angiogenesis [38] . PGE 2 also induces HIF-1α stabilization and nuclear localization in a human prostate cancer cell line [39] . These findings propose that Cox-2 and PGE 2 might promote survivin expression by indirectly modifying the HIF-1α pathway. On the other hand, hypoxia-induced survivin expression is preserved by the sustained rise of Cox-2 expression and PGE 2 production in HUVECs exposed to hypoxia, suggesting that Cox-2 may be a potential mediator for hypoxia-induced survivin expression. Hypoxia-driven survivin expression in cancer cells is also reliant on the Cox-2 pathway [40] .
It has been found that blocking the HIF-1α pathway by inhibitors such as genistein [41, 42] and YC-1 [43, 44] results in the down-regulation of survivin expression in tumor cells, diminishing angiogenesis and tumor growth. Genistein exhibited a similar effect in the present study, in which HIF-1α-mediated survivin expression under hypoxic conditions and HIF-1α inhibition by genistein in HUVECs led to reduced rather than completely diminished survivin expression, even in the presence of 200 μM of genistein, implying that hypoxiainduced survivin expression can be initiated through other molecular pathways besides HIF-1α. To the best of our knowledge, this is the first study that shows survivin expression can be stimulated by hypoxia and CoCl2-induced HIF-1α accumulation in HUVECs in a time-dependent manner, although other studies have found hypoxia up-regulates survivin expression in cancer cell lines [45] .
We propose that hypoxia-induced survivin expression is regulated through dual interdependent mechanisms directly involving HIF-1α and indirectly involving the Cox-2/ PGE 2 pathways in HUVECs. Accordingly, celecoxib may have inhibited survivin expression through blocking the Cox-2/PGE 2 pathway. Although the apoptosis pathways for survivin regulation were not investigated in our study, it still could be assumed that Cox-2 suppression by celecoxib plays important roles in inhibiting hypoxia-induced survivin expression. Other transcription factors may also be involved in hypoxia-induced survivin expression and therefore warrant further investigation.
In conclusion, for the first time, our study observed that hypoxia-induced survivin expression in HUVECs may be mediated through dual interdependent mechanisms directly involving HIF-1α and indirectly involving the Cox-2/PGE 2 pathways, and celecoxib may offset hypoxia-induced survivin expression. The findings propose the potentially therapeutic value of celecoxib in the treatment of pathologic ocular vascular disease.
